Brazil Pharma Plans Follow-on

Brazil Pharma plans to raise BRL600m ($316m) in an equity follow-on, it says. It does not specify the exact timing. The retail pharmaceutical operator notes that 86% of the offer will be primary shares. BTG Pactual is the lead manager, to be joined by additional banks. Brazil Pharma raised BRL465.75m in its IPO last year, done through Bradesco, BTG, and Morgan Stanley.